Novel approaches in fighting herpes simplex virus infections
about
New strategies against drug resistance to herpes simplex virusThe challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccineHSV usurps eukaryotic initiation factor 3 subunit M for viral protein translation: novel prevention target.An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challengeProphylactic and therapeutic modulation of innate and adaptive immunity against mucosal infection of herpes simplex virusHSV activates Akt to trigger calcium release and promote viral entry: novel candidate target for treatment and suppression.The Effect of Aqueous Extract of Glycyrrhiza glabra on Herpes Simplex Virus 1.Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection.CMX001 potentiates the efficacy of acyclovir in herpes simplex virus infectionsNanomedicine as an emerging approach against intracellular pathogensDynasore disrupts trafficking of herpes simplex virus proteinsIn vitro studies of the antiherpetic effect of photodynamic therapy.A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections.Glutamine and leucine provide enhanced protective immunity against mucosal infection with herpes simplex virus type 1.Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention.Clinical efficacy of oral ganciclovir for prophylaxis and treatment of recurrent herpes simplex keratitis.Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeuticsTreatment of herpes simplex virus infections in pediatric patients: current status and future needs.Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activityAn investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection.Systemic nucleoside antiviral agents may be effective in prevention of recurrent herpes labialis.Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents.Targeted lipid based drug conjugates: a novel strategy for drug delivery.In vitro and in vivo evaluation of a novel antiherpetic flavonoid, 4'-phenylflavone, and its synergistic actions with acyclovir.Corilagin Protects Against HSV1 Encephalitis Through Inhibiting the TLR2 Signaling Pathways In Vivo and In Vitro.Synthesis and antiviral activity of 1-(1,3-disubstitutedimidazolidyn-2-ylidene)-3-ethoxycarbonylmethylurea derivatives.Immunization with DNA vaccine expressing herpes simplex virus type 1 gD and IL-21 protects against mouse herpes keratitis.Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity.Design, Synthesis, and Biological Evaluation of γ-Aminopropyl Silatrane-Acyclovir Hybrids with Immunomodulatory Effects.
P2860
Q26749548-1D78C009-8342-4694-8A65-0A84B089F812Q27021292-102D81B2-1F99-445B-A3A8-EB3F6AB3DA55Q33646802-4A5B59C5-FD20-4418-925A-171C6F7056D1Q33916162-5AE72244-FF12-4B93-99D0-5D48D7B2F40AQ34105712-A604B6A5-83FA-40F8-8835-DDC5C697FD28Q34333815-9F3AAB12-9137-432F-B699-2B8D712104EBQ34437502-133FD098-8E47-4DA8-B90A-796F311455C6Q34495644-2BEB6CE5-A131-4ED4-BA8E-C888294798AFQ35270714-BC0FA670-C82E-4051-ACBB-8F6DA4381BF1Q35656908-FE2A4E7B-7146-4785-A3AE-2A5EE1CB5EC4Q35745437-A9BCEC95-BF4E-4165-A8B4-05AF5C07A4E2Q35966445-59ACC65A-B4CA-4DDA-84B1-07A47F2B818FQ36086635-3678BB16-56AF-41D7-97B6-7B6BC9C4ECCCQ36431020-F1248CC2-4D33-4F95-9E9F-904987BC51F8Q36607185-FB9BA3FC-7D17-4BAC-8E4A-8E45A027FC1EQ36765590-04738D8C-D0F9-4508-90EB-0AA5600012B2Q36816198-8F95BD6E-E139-48F2-AF3B-C6585CA5991DQ36866689-A8B12743-B139-4A34-AA9F-E4113D5A0763Q36938445-AC58B2BC-F314-4A2C-BC25-EFA3778C9010Q37103787-D61FAE9E-3B2E-4DEE-AEEE-69121D9F80E6Q37208892-EF26724C-853C-4535-A6B4-18C7C14BE333Q38116317-7DD37015-6229-4C1A-A74B-64096E6BE831Q38858400-13AA9E76-C22F-4B53-B5EB-8839894F9C33Q39332407-FA6ECC35-9A75-431B-8FAC-7A31DC640881Q39349292-57AF9C0D-3B74-45D3-8A3A-36F40EFB1E10Q41678491-11F1447B-018D-4CFE-BFB0-05E59FE4B5B6Q42153196-D5DB43FB-81E1-421A-9112-0FA5B4A191FAQ45370073-D5CD693E-BDF4-4201-B1BB-857413C74B85Q45372480-0D7D73B3-C33F-42F7-9BB1-1445741E603FQ51066899-D7AC78B4-59E5-442E-A02A-54914DF97F80
P2860
Novel approaches in fighting herpes simplex virus infections
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel approaches in fighting herpes simplex virus infections
@en
Novel approaches in fighting herpes simplex virus infections.
@nl
type
label
Novel approaches in fighting herpes simplex virus infections
@en
Novel approaches in fighting herpes simplex virus infections.
@nl
prefLabel
Novel approaches in fighting herpes simplex virus infections
@en
Novel approaches in fighting herpes simplex virus infections.
@nl
P2093
P2860
P356
P1476
Novel approaches in fighting herpes simplex virus infections
@en
P2093
Betsy C Herold
Esra Fakioglu
Sarah S Wilson
P2860
P304
P356
10.1586/ERI.09.34
P577
2009-06-01T00:00:00Z